William Blair analyst Andy Hsieh downgrades Actinium Pharmaceuticals (AMEX:ATNM) from Outperform to Market Perform.
Deep Dive Into Lear Stock: Analyst Perspectives (8 Ratings)
Across the recent three months, 8 analysts have shared their insights on Lear (NYSE:LEA), expressing a variety of…